Ocugen (OCGN) Assets Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.72% |
| Dec 31, 2025 | -47.22% |
| Sep 30, 2025 | -7.01% |
| Jun 30, 2025 | 32.19% |
| Mar 31, 2025 | 24.45% |
| Dec 31, 2024 | 27.72% |
| Sep 30, 2024 | -17.07% |
| Jun 30, 2024 | -54.43% |
| Mar 31, 2024 | -46.22% |
| Dec 31, 2023 | -40.58% |
| Sep 30, 2023 | -35.75% |
| Jun 30, 2023 | -31.60% |
| Mar 31, 2023 | -32.05% |
| Dec 31, 2022 | 2.71% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | 4.70% |
| Mar 31, 2022 | 163.20% |
| Dec 31, 2021 | 286.33% |
| Sep 30, 2021 | 466.28% |
| Jun 30, 2021 | 422.97% |
| Mar 31, 2021 | 337.29% |
| Dec 31, 2020 | 62.88% |
| Sep 30, 2020 | -13.04% |
| Jun 30, 2020 | 642.47% |
| Mar 31, 2020 | -17.01% |
| Dec 31, 2019 | 584.83% |
| Sep 30, 2019 | 117.07% |
| Jun 30, 2019 | -78.88% |
| Mar 31, 2019 | -30.42% |
| Dec 31, 2018 | -77.76% |
| Sep 30, 2018 | -31.25% |
| Jun 30, 2018 | -31.53% |
| Mar 31, 2018 | -24.67% |
| Dec 31, 2017 | -69.41% |
| Sep 30, 2017 | -63.01% |
| Jun 30, 2017 | 3.99% |
| Mar 31, 2017 | -0.72% |
| Dec 31, 2016 | -1.92% |
| Sep 30, 2016 | -5.53% |
| Jun 30, 2016 | -60.03% |
| Mar 31, 2016 | -53.69% |
| Dec 31, 2015 | -43.84% |